Cost–Effectiveness of Rivaroxaban Compared to Warfarin for Stroke Prevention in Atrial Fibrillation von Lee, Soyon, PharmD, Anglade, Moise W., MD, Pham, Dan, BS, Pisacane, Robyn, BS, Kluger, Jeffrey, MD, Coleman, Craig I., PharmD

Volltext

Use of N-acetylcysteine to reduce post-cardiothoracic surgery complications: a meta-analysis von Baker, William L., Anglade, Moise W., Baker, Erica L., White, Charles Michael, Kluger, Jeffrey, Coleman, Craig I.

Volltext

Cost–Effectiveness of Clopidogrel Plus Aspirin for Stroke Prevention in Patients With Atrial Fibrillation in Whom Warfarin Is Unsuitable von Coleman, Craig I., PharmD, Straznitskas, Andrew D., PharmD, Sobieraj, Diana M., PharmD, Kluger, Jeffrey, MD, Anglade, Moise W., MD

Volltext

Cost-Effectiveness of Apixaban Compared With Aspirin for Stroke Prevention in Atrial Fibrillation Among Patients Unsuitable for Warfarin von LEE, Soyon, ANGLADE, Moise W, MENG, Joy, HAGSTROM, Kelly, KLUGER, Jeffrey, COLEMAN, Craig I

Volltext

Thiazolidinedione use and post-operative atrial fibrillation: a US nested case-control study von Anglade, Moise W., Kluger, Jeffrey, Michael White, C., Aberle, Jeffrey, Coleman, Craig I.

Volltext

Predictors of disease severity in patients admitted to a cholera treatment center in urban Haiti von Valcin, Claude-Lyne, Severe, Karine, Riche, Claudia T, Anglade, Benedict S, Moise, Colette Guiteau, Woodworth, Michael, Charles, Macarthur, Li, Zhongze, Joseph, Patrice, Pape, Jean W, Wright, Peter F

Volltext